|
Acumen Physician Solutions Products to Interface with DSI Renal - PharmiWeb.com (press release) |
 |
 |
|
Acumen Physician Solutions will join with DSI Renal to interface with DSI’s proprietary electronic medical records. In turn DSI the third-largest dialysis services company will recommend using Acumen software in its dialysis units.
DSI’s relationship with Acumen reinforces the companies’ joint commitment to physicians. DSI and Acumen worked together to upgrade their respective systems to allow physician rounding notes from Acumen to flow seamlessly into DSI’s clinical system (PEARL) eliminating double entry and ensuring compliance.
“This partnership will provide increased visibility within the U.S. health care industry for both Acumen and DSI Renal” said Acumen president Dana Hensley. “Acumen’s biotechnology has been used in nephrology practices nationwide and we’re ready to partner with a large dialysis services company.”
DSI Renal will recommend using Acumen’s electronic health records (EHR) system as well as Mobile Charge Capture a mobile application that works within a nephrology practice management system to streamline the patient-to-doctor communication process. Mobile Charge Capture is designed to minimize error and promote accuracy within EHR systems. It can be used in the dialysis center lab or hospital and is compatible with an iPad iPhone or PC.
“Physicians’ patients and caseloads are increasing every day so anything their partners and vendors can do to reduce the administrative burden allows physicians to spend more time with patients and increases the efficiency of the overall health care system” said DSI Renal executive vice president Judy Lefkovitz. “These time-saving requested enhancements show the commitment that DSI and Acumen have to their physician partners.”
About Acumen Physician Solutions
Acumen Physician Solutions was formed to develop and deliver intuitive software tools to assist nephrologists in the practice of medicine. The Acumen solution was designed by nephrologists and made available under an Internet-based service model. Our products include: Acumen Practice Management Acumen Plus Acumen Mobile Charge Capture Acumen nEHR and Acumen PQRS. Acumen Physician Solutions based in Franklin Tenn. is a wholly owned subsidiary of Fresenius Medical Care North America. More information regarding Acumen Physician Solutions and Acumen Nephrology can be found at www.AcumenMD.com.
About DSI Renal
DSI Renal (formed as Dialysis Newco Inc.) is a leading provider of dialysis services in the United States offering state-of-the-art treatment for patients suffering from chronic kidney failure and renal disease. Together with its physician partners DSI Renal owns and operates 92 dialysis clinics in 22 states. The company plans for growth through acquisition and development of new clinics as well as through establishment of additional joint venture partnerships with leading nephrologists for the clinic hospital and alternative settings. For more information please visit www.dsi-corp.com.
Business Wire
http://www.businesswire.com/
Last updated on: 05/05/2015
|
|
Acumen Physician Solutions Products to Interface with DSI Renal - Yahoo Finance UK |
|
|
|
NASHVILLE, Tenn.--(BUSINESS WIRE)--
Acumen Physician Solutions will join with DSI Renal to interface with DSI’s proprietary electronic medical records. In turn, DSI, the third-largest dialysis services company, will recommend using Acumen software in its dialysis units.
DSI’s relationship with Acumen reinforces the companies’ joint commitment to physicians. DSI and Acumen worked together to upgrade their respective systems to allow physician rounding notes from Acumen to flow seamlessly into DSI’s clinical system (PEARL), eliminating double entry and ensuring compliance.
“This partnership will provide increased visibility within the U.S. health care industry for both Acumen and DSI Renal,” said Acumen president Dana Hensley. “Acumen’s biotechnology has been used in nephrology practices nationwide, and we’re ready to partner with a large dialysis services company.”
DSI Renal will recommend using Acumen’s electronic health records (EHR) system as well as Mobile Charge Capture, a mobile application that works within a nephrology practice management system to streamline the patient-to-doctor communication process. Mobile Charge Capture is designed to minimize error and promote accuracy within EHR systems. It can be used in the dialysis center, lab or hospital, and is compatible with an iPad, iPhone or PC.
“Physicians’ patients and caseloads are increasing every day, so anything their partners and vendors can do to reduce the administrative burden allows physicians to spend more time with patients and increases the efficiency of the overall health care system,” said DSI Renal executive vice president Judy Lefkovitz. “These time-saving, requested enhancements show the commitment that DSI and Acumen have to their physician partners.”
About Acumen Physician Solutions
Acumen Physician Solutions was formed to develop and deliver intuitive software tools to assist nephrologists in the practice of medicine. The Acumen solution was designed by nephrologists and made available under an Internet-based service model. Our products include: Acumen Practice Management, Acumen Plus, Acumen Mobile Charge Capture, Acumen nEHR and Acumen PQRS. Acumen Physician Solutions, based in Franklin, Tenn., is a wholly owned subsidiary of Fresenius Medical Care North America. More information regarding Acumen Physician Solutions and Acumen Nephrology can be found at www.AcumenMD.com.
About DSI Renal
DSI Renal (formed as Dialysis Newco, Inc.) is a leading provider of dialysis services in the United States, offering state-of-the-art treatment for patients suffering from chronic kidney failure and renal disease. Together with its physician partners, DSI Renal owns and operates 92 dialysis clinics in 22 states. The company plans for growth through acquisition and development of new clinics as well as through establishment of additional joint venture partnerships with leading nephrologists for the clinic, hospital and alternative settings. For more information, please visit www.dsi-corp.com.
<![CDATA[.bwalignc {text-align: center !important;} ;} ]]>
|
|
|
Acumen Physician Solutions Products to Interface with DSI Renal - Business Wire (press release) |
|
|
|
NASHVILLE, Tenn.--(BUSINESS WIRE)--Acumen Physician Solutions will join with DSI Renal to interface with DSI’s proprietary electronic medical records. In turn, DSI, the third-largest dialysis services company, will recommend using Acumen software in its dialysis units.
DSI’s relationship with Acumen reinforces the companies’ joint commitment to physicians. DSI and Acumen worked together to upgrade their respective systems to allow physician rounding notes from Acumen to flow seamlessly into DSI’s clinical system (PEARL), eliminating double entry and ensuring compliance.
“This partnership will provide increased visibility within the U.S. health care industry for both Acumen and DSI Renal,” said Acumen president Dana Hensley. “Acumen’s biotechnology has been used in nephrology practices nationwide, and we’re ready to partner with a large dialysis services company.”
DSI Renal will recommend using Acumen’s electronic health records (EHR) system as well as Mobile Charge Capture, a mobile application that works within a nephrology practice management system to streamline the patient-to-doctor communication process. Mobile Charge Capture is designed to minimize error and promote accuracy within EHR systems. It can be used in the dialysis center, lab or hospital, and is compatible with an iPad, iPhone or PC.
“Physicians’ patients and caseloads are increasing every day, so anything their partners and vendors can do to reduce the administrative burden allows physicians to spend more time with patients and increases the efficiency of the overall health care system,” said DSI Renal executive vice president Judy Lefkovitz. “These time-saving, requested enhancements show the commitment that DSI and Acumen have to their physician partners.”
About Acumen Physician Solutions
Acumen Physician Solutions was formed to develop and deliver intuitive software tools to assist nephrologists in the practice of medicine. The Acumen solution was designed by nephrologists and made available under an Internet-based service model. Our products include: Acumen Practice Management, Acumen Plus, Acumen Mobile Charge Capture, Acumen nEHR and Acumen PQRS. Acumen Physician Solutions, based in Franklin, Tenn., is a wholly owned subsidiary of Fresenius Medical Care North America. More information regarding Acumen Physician Solutions and Acumen Nephrology can be found at www.AcumenMD.com.
About DSI Renal
DSI Renal (formed as Dialysis Newco, Inc.) is a leading provider of dialysis services in the United States, offering state-of-the-art treatment for patients suffering from chronic kidney failure and renal disease. Together with its physician partners, DSI Renal owns and operates 92 dialysis clinics in 22 states. The company plans for growth through acquisition and development of new clinics as well as through establishment of additional joint venture partnerships with leading nephrologists for the clinic, hospital and alternative settings. For more information, please visit www.dsi-corp.com.
|
|
PPIs, Low Magnesium Linked in Renal Transplant Patients - Renal and Urology News |
|
|
May 04, 2015
Study of renal transplant patients also shows that proton pump inhibitors are associated with increased arterial stiffness.
PHILADELPHIA—Proton pump inhibitor (PPI) use is associated with decreased magnesium absorption and increased arterial stiffness in renal transplant recipients, according to a new study presented at the 2015 American Transplant Congress.
Siren Sezer, MD, and colleagues at the Baskent University in Ankara, Turkey, retrospectively studied 354 renal transplant recipients with a mean age of 38.6 years and stable graft function. All had received their transplant at least 36 months previously. The researchers divided subjects into 3 groups: PPI users (164 patients); H2 receptor blocker users (96 patients); and a control group not taking any stomach-protecting agents (94 patients).
The PPI group had a significantly lower mean serum magnesium level compared with the H2 receptor block group and control group (1.5 vs. 1.7 and 1.7 mg/dL).
The researchers measured pulse wave velocity (PWv) to assess arterial stiffness. PWv values were significantly higher in the PPI group than the H2 receptor block group and control group (7.3 vs. 6.3 and 6.2 cm/sec, respectively).
|
|
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
